arrow_back Back to App

New center to combat import of synthetic drugs, including fentanyl.

This act establishes a new center within the Drug Enforcement Administration (DEA) to track and halt the flow of synthetic drugs, especially fentanyl. Its goal is to enhance public safety by reducing the availability of illegal substances, which can impact citizens' health and lives. The center will coordinate efforts across multiple agencies to more effectively combat drug trafficking.
Key points
A National Center to Stop the Import of Illicit Synthetic Drugs is established within the DEA.
The Center will be the primary organization for analyzing, tracking, and halting the movement of synthetic drugs domestically and internationally.
It will coordinate efforts of various government agencies to more effectively dismantle synthetic drug trade networks.
The Director of the Center will serve as the principal advisor to the President on the synthetic drug trade.
The Center is set to operate for five years, with a possible two-year extension.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_2616
Sponsor: Rep. Pettersen, Brittany [D-CO-7]
Process start date: 2023-04-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Stop the Import of Fentanyl Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_2616.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-04-13.

What are the main provisions?

Key points include:

  • A National Center to Stop the Import of Illicit Synthetic Drugs is established within the DEA.
  • The Center will be the primary organization for analyzing, tracking, and halting the movement of synthetic drugs domestically and internationally.
  • It will coordinate efforts of various government agencies to more effectively dismantle synthetic drug trade networks.
  • The Director of the Center will serve as the principal advisor to the President on the synthetic drug trade.
  • The Center is set to operate for five years, with a possible two-year extension.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Pettersen, Brittany [D-CO-7].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on the Judiciary.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Security Courts and Law Health